NIH-funded research P01 program project

ABCC1 and beta2-adrenergic signals in airway smooth muscle

Official title: ABCC1 mediates b2AR effects on excitation-contraction (E-C) coupling of human airway smooth muscle

Funded at Thomas Jefferson University · NIH-11417202 · Data updated 2026-11-12

A study to understand how a transporter protein ABCC1 affects howAirway smooth muscle relaxes in response to beta2-adrenergic medicines for asthma.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionThomas Jefferson University
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startSeptember 20, 2025
Project endJuly 31, 2030
Funding year2026
Award (this year)$332,180
NIH project number5P01HL180318-02
Project IDNIH-11417202 on NIH RePORTER

Who could benefit from this research

Could help

Adults with asthma or airway symptoms who could contribute tissue samples or be considered for future trials.

Less likely to help

People without asthma or who cannot provide or consent to tissue samples may not directly benefit from this study.

What this research studies

This project looks at how ABCC1 influences the way airway smooth muscle responds to beta2-adrenergic drugs, which are commonly used to treat asthma. Researchers will test how ABCC1 activity changes intracellular cAMP levels and muscle relaxation, and whether CK2 and MAPK pathways modify ABCC1’s role. The work will involve examining human airway smooth muscle samples and relevant cellular models to map the signaling steps from receptor activation to muscle relaxation. The findings could reveal new ways to improve asthma therapies by targeting ABCC1-related pathways. The study spans lab experiments over several years to test the central hypothesis and aims.

Why it matters

Potential benefit: If successful, the research could lead to enhanced asthma treatments that make beta2-agonists more effective.

How similar studies have gone: Prior work showed ABCC1 involvement in cAMP handling and airway relaxation, supporting potential translational relevance.

Where this research is happening

  • Thomas Jefferson University
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Panettieri, Reynold Alexander — Thomas Jefferson University
  • Study coordinator: Panettieri, Reynold Alexander

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.